119 related articles for article (PubMed ID: 38042460)
1. Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV.
Rigo-Bonnin R; García-Tejada L; Mas-Bosch V; Imaz A; Manuel Tiraboschi J; Scévola S; Niubó J; Navarro-Alcaraz A; Podzamczer D
Clin Chim Acta; 2024 Jan; 552():117678. PubMed ID: 38042460
[TBL] [Abstract][Full Text] [Related]
2. Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS/MS.
Rigo-Bonnin R; Tiraboschi JM; Álvarez-Álvarez M; Pérez-Fernández GA; Sanjuás-Iglesias M; Scévola S; Niubó J; Videla S; Podzamczer D
J Pharm Biomed Anal; 2020 Jun; 185():113250. PubMed ID: 32199329
[TBL] [Abstract][Full Text] [Related]
3. Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis.
Rigo-Bonnin R; Rosselló-Palmer E; Sánchez-García A; Pallarés-Borràs M; Martínez Y; Videla S; Otero A; Lloberas N; Hueso M
Clin Chim Acta; 2023 Sep; 549():117554. PubMed ID: 37704005
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
Courlet P; Alves Saldanha S; Cavassini M; Marzolini C; Choong E; Csajka C; Günthard HF; André P; Buclin T; Desfontaine V; Decosterd LA
J Mass Spectrom; 2020 Jun; 55(6):e4506. PubMed ID: 32160389
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
West RE; Oberly PJ; Riddler SA; Nolin TD; Devanathan AS
J Pharm Biomed Anal; 2024 Mar; 240():115932. PubMed ID: 38198884
[TBL] [Abstract][Full Text] [Related]
6. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
West RE; Oberly PJ; Saylor AJ; Riddler SA; Nolin TD; Devanathan AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124164. PubMed ID: 38823149
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma.
Rigo-Bonnin R; Ribera A; Arbiol-Roca A; Cobo-Sacristán S; Padullés A; Murillo Ò; Shaw E; Granada R; Pérez-Fernández XL; Tubau F; Alía P
Clin Chim Acta; 2017 May; 468():215-224. PubMed ID: 28288784
[TBL] [Abstract][Full Text] [Related]
9. Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
Croteau D; Rossi SS; Best BM; Capparelli E; Ellis RJ; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur J; McCutchan JA; Morgello S; Simpson DM; Grant I; Letendre S;
J Antimicrob Chemother; 2013 Mar; 68(3):684-9. PubMed ID: 23143899
[TBL] [Abstract][Full Text] [Related]
10. Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections.
Rigo-Bonnin R; Gomez-Junyent J; García-Tejada L; Benavent E; Soldevila L; Tubau F; Murillo O
Clin Chim Acta; 2019 Jan; 488():50-60. PubMed ID: 30385280
[TBL] [Abstract][Full Text] [Related]
11. Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interaction.
Belkhir L; De Laveleye M; Vandercam B; Zech F; Delongie KA; Capron A; Yombi J; Vincent A; Elens L; Haufroid V
Clin Biochem; 2016 May; 49(7-8):580-6. PubMed ID: 26742721
[TBL] [Abstract][Full Text] [Related]
12. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
[TBL] [Abstract][Full Text] [Related]
13. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A
J Pharm Biomed Anal; 2017 May; 138():223-230. PubMed ID: 28219799
[TBL] [Abstract][Full Text] [Related]
16. Determination of unbound fraction of dorzagliatin in human plasma by equilibrium dialysis and LC-MS/MS and its application to a clinical pharmacokinetic study.
Yang R; Ren S; Jin X; Sun Y; Dong Y; Zhang J; Liang W; Chen L
J Pharm Biomed Anal; 2021 Feb; 195():113854. PubMed ID: 33388639
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.
Reddy AV; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J; Madhavi G
J Sep Sci; 2015 Aug; 38(15):2580-7. PubMed ID: 25989063
[TBL] [Abstract][Full Text] [Related]
18. Application of a validated ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of darunavir in human plasma for a bioequivalence study in Indian subjects.
Gupta A; Singhal P; Shrivastav PS; Sanyal M
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2443-53. PubMed ID: 21788160
[TBL] [Abstract][Full Text] [Related]
19. Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Rigo-Bonnin R; Cobo-Sacristán S; Gonzalo-Diego N; Colom H; Muñoz-Sánchez C; Urruticoechea A; Falo C; Alía P
J Pharm Biomed Anal; 2016 Jan; 117():140-9. PubMed ID: 26350560
[TBL] [Abstract][Full Text] [Related]
20. Measurement of ceftazidime concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Application to critically ill patients and patients with osteoarticular infections.
Rigo-Bonnin R; Cobo-Sacristán S; Padullés A; Ribera A; Arbiol-Roca A; Murillo Ó; Sabater-Riera J; Alía P
Biomed Chromatogr; 2016 Mar; 30(3):410-8. PubMed ID: 26184353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
